Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001209191-21-009413

Director acquired 2,407,328 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2021-02-08 Conversion +2,407,328 4,690,153 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2021-02-08 Conversion · Series AA Preferred Convertible Stock −110,729,827 0 I: show line 2 in the form
Peyer James Director 2021-02-08 Conversion · Series BB Preferred Convertible Stock −4,821,996 0 I: show line 3 in the form
Loading xslF345X03/doc4.xml…